Skip to main content
OpenTrials
Completed

NCT Number: NCT00468793

Traditional Versus ScvO2 Guided Perioperative Fluid Therapy

Perioperative goal directed fluid therapy by means of an esophageal doppler has been shown to reduce morbidity and length of stay. In this study patients undergoing elective bowel surgery will be randomised to traditional fluid therapy with crystalloids versus fluid boluses guided by central venous oxygen saturation. The primary outcome will be complications after surgery.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Haukeland University Hospital

Bergen, 5021, Norway

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Elective bowel surgery,
  • Able to give informed consent

Exclusion criteria

  • Coagulation defect,
  • Renal failure,
  • Valvular stenosis

Treatment and study plan

Intravenous fluid

Procedure

The same intravenous fluids will be used in both arms but the volume will be different

Primary outcomes

  1. Postoperative morbidity

    Time frame: postoperative day 30

Secondary outcomes

  1. serum creatinine

    Time frame: postoperative day 3

Sponsors and collaborators

Lead sponsor

Haukeland University Hospital

Other

Registry information

Official study title

Randomized Clinical Study of Traditional Versus ScvO2 Guided Perioperative Fluid Therapy

Important dates

Study start
2007
Primary completion
2009
Study completion
2009
First posted
May 3, 2007
Registry last updated
Jun 10, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.